Bill Maris

Bill Maris
Bill Maris is a venture capitalist and the CEO at GV, a venture capital firm established by Maris and funded through Alphabet. With approximately $2.4 billion under management and investments in Uber and Nest, the six-year-old fund is described as one of the hottest in Silicon Valley. Maris oversees all of GV’s funding activity and has a particular interest in next generation life sciences and artificial intelligence. He was instrumental in the formation of Google’s Calico project...
NationalityAmerican
ProfessionBusinessman
CountryUnited States of America
There are a number of start-ups in Europe that are able to reach beyond their own country. Take Spotify - Spotify just in Sweden isn't that interesting compared to Spotify all over the world.
We have this powerful lever at Google Ventures, which is to invest $200 million a year. This is a huge lever. It's not all going into one place; it's going into lots of start ups and founders and entrepreneurs, all of which are levers to try and change the world in one way or another.
You make a great investment in the consumer Internet, maybe you make a lot of money and create something useful, interesting, or fun. But in life sciences, you have a chance to be part of something that lets people live longer and healthier and not lose the people they care about. That is really profound.
With a regular venture fund, you raise, let's say, a billion dollars, and then over the next three or four years, you've got to invest that money; otherwise, the people who invested with you will say, 'What are you doing? You're just collecting fees on our money.'
We actually have the tools in the life sciences to achieve anything that you have the audacity to envision. I just hope to live long enough not to die.
We are looking for highly technical, enthusiastic and capable entrepreneurs who have a healthy disregard for the impossible, and that's not always easy to find.
There are a lot of billionaires in Silicon Valley, but in the end, we are all heading to the same place. If given the choice between making a lot of money or finding a way to make people live longer, what do you choose?
The reality is the technology exists now to extend life and have people live healthier, happier lives. Not to be kind of immortal - that's not what I'm talking about.
There are environmental threats to health; there are internal threats to health - genetic conditions, viral threats, diseases like cancer and Parkinson's. And then there are societal and global ones, like poverty and lack of nutrition. And unknown viral threats - everything from a new kind of influenza to hemorrhagic fever.
Venture funds get beaten up for not investing in important things. Okay, if you want venture funds to invest in important things, then don't penalize or make fun of them when those important things don't work.
You want to work with people you are excited about and they are excited about you. It's a two-way street.
Big ideas we tend to like are the ones that seem impossible or crazy.
In genomics, there's a massive amount of information in which you can look for patterns and develop insights.
When you build relationships with entrepreneurs, they're not trying to optimize on price.